The CDC expanded RSV vaccine recommendations to include adults aged 50 and above who have underlying health conditions ...

Reports second quarter revenues of $0.1 billion, GAAP net loss of $(0.8) billion and GAAP EPS of $(2.13) Updates 2025 ...

The health and human services secretary and noted vaccine skeptic named a new panel to provide the guidance often used by ...

Moderna, Inc.'s Q2 2025 earnings highlight a steep revenue decline post-pandemic, with just $0.1bn in revenue and a $(0.8bn) ...

Merck Unveils New Facility to Increase Vaccine Production CapacityDURHAM, N.C.-- (BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today the ...